PATENT CLAIM ANALYSIS

Application Number: 15755481
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-09
Patent Classification: ["514", "04400A"]

Abstract:
The present invention relates to novel isolated nucleic acid molecules (novel miRNAs and novel miRNA precursor molecules) as well as vectors, host cells, primers, cDNA-transcripts, polynucleotides derived from said isolated nucleic acid molecules and their use in diagnosis and therapy. Furthermore the present invention relates to methods and kits for diagnosing a disease, such as Multiple Sclerosis (MS) or Alzheimer's Disease (AD) employing said novel isolated nucleic acid molecules (novel miRNAs molecules).

Claim (Index 1):
An isolated nucleic acid molecule comprising a nucleotide sequence selected from the group consisting of SEQ ID NO: 2, SEQ ID NO: 1, SEQ ID NO: 3 to SEQ ID NO: 37, a fragment thereof, and a nucleotide sequence with at least 90%, 94%, 96% or greater sequence identity thereto.

Metadata:
- Claim Count in Document: 30.0
- Percentile: 88.0
- Lexical Diversity: 1.69231
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14383518', '14873385', '13376225', '14442439', '11747409']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7901972869083875
- 35 USC 102 Novelty (BERT): 0.5373174047155447
- Combined Prediction Score: 0.7649092986891033
- Mean Citation Score: 349.89538000000016
- Max Citation Score: 386.3022
- Similarity Product: 267.9332649601579

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test